Logo

Yury Rozenman, Whaijen Soo

Dec 23, 2002
Premium

Yury Rozenman has left his position as director of life science business development at Platform Computing to join IBM as global pharmaceutical marketing manager. Prior to Platform, Rozenman was senior vice president of supercomputing and bioinformatics at Juno Online Services and a senior software consultant at Applied Biosystems.

Biogen has appointed Whaijen Soo as senior vice president, medical research. Soo most recently served as vice president, clinical sciences, at Roche. During his tenure at Roche, Soo headed the oncology, virology, and transplant areas and built the company’s genomics and bioinformatics capabilities.

Filed under

Informatics
Breaking News
The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.